Copulsing tumor antigen-pulsed dendritic cells with zoledronate efficiently enhance the expansion of tumor antigen-specific CD8+ T cells via Vγ9γδ T cell activation

Journal of Leukocyte Biology

Volumn 83, Issue 3, 2008, Pages 742-754

  Takahara, Masashi ^a   Miyai, Manami ^a   Tomiyama, Mai ^a   Mutou, Masato ^a   Nicol, Andrew J ^b   Nieda, Mie ^a,c  

^a Medinet Medical Institute   (Japan)

^b UNIVERSITY OF QUEENSLAND   (Australia)

^c MEDINET Co Ltd   (Japan)

Author keywords

Adjuvants; Aminobisphophonates; CTLs; Human

Indexed keywords

CD40 LIGAND; GAMMA INTERFERON; HLA A ANTIGEN; MELAN A; TUMOR ANTIGEN; ZOLEDRONIC ACID; BISPHOSPHONIC ACID DERIVATIVE; BONE DENSITY CONSERVATION AGENT; CD8 ANTIGEN; IMIDAZOLE DERIVATIVE; LYMPHOCYTE ANTIGEN RECEPTOR; MONOCLONAL ANTIBODY;

CD8+ T LYMPHOCYTE; CELL FUNCTION; CELL PROLIFERATION; CONFERENCE PAPER; CONTROLLED STUDY; CYTOKINE PRODUCTION; DENDRITIC CELL; DRUG EFFECT; HUMAN; HUMAN CELL; IMMUNE RESPONSE; INNATE IMMUNITY; LYMPHOCYTE; NORMAL HUMAN; PRIORITY JOURNAL; T LYMPHOCYTE; T LYMPHOCYTE ACTIVATION; TUMOR CELL LINE; TUMOR IMMUNITY; VGAMMA9GAMMADELTA T CELL; ARTICLE; CULTURE TECHNIQUE; CYTOTOXIC T LYMPHOCYTE; IMMUNOLOGY; LYMPHOCYTE ACTIVATION;

ANTIBODIES, MONOCLONAL; ANTIGENS, CD8; ANTIGENS, NEOPLASM; BONE DENSITY CONSERVATION AGENTS; CD8-POSITIVE T-LYMPHOCYTES; CELL CULTURE TECHNIQUES; DENDRITIC CELLS; DIPHOSPHONATES; HUMANS; IMIDAZOLES; LYMPHOCYTE ACTIVATION; RECEPTORS, ANTIGEN, T-CELL, GAMMA-DELTA; T-LYMPHOCYTES, CYTOTOXIC;

EID: 43349102822     PISSN: 07415400     EISSN: None     Source Type: Journal    
DOI: 10.1189/jlb.0307185     Document Type: Conference Paper

References (54)

1. Conrad, C., Nestle, F. O. (2003) Dendritic cell-based cancer therapy. Curr. Opin. Mol. Ther. 5, 405-412.
2. Cerundolo, V., Hermans, I. F., Salio, M. (2004) Dendritic cells: a journey from laboratory to clinic. Nat. Immunol. 5, 7-10.
3. Hsu, F. J., Benike, C., Fagnoni, F., Liles, T. M., Czerwinski, D., Taidi, B., Engleman, E. G., Levy, R. (1996) Vaccination of patients with B-cell lymphoma using autologous antigen-pulsed dendritic cells. Nat. Med. 2, 52-58.
4. Nestle, F. O., Alijagic, S., Gilliet, M., Sun, Y., Grabbe, S., Dummer, R., Burg, G., Schadendorf, D. (1998) Vaccination of melanoma patients with peptide- or tumor lysate-pulsed dendritic cells. Nat. Med. 4, 328-332.
5. Fong, L., Hou, Y., Rivas, A., Benike, C., Yuen, A., Fisher, G. A., Davis, M. M., Engleman, E. G. (2001) Altered peptide ligand vaccination with Flt3 ligand expanded dendritic cells for tumor immunotherapy. Proc. Natl. Acad. Sci. USA 98, 8809-8814.
6. Banchereau, J., Palucka, A. K. (2005) Dendritic cells as therapeutic vaccines against cancer. Nat. Rev. Immunol. 5, 296-306.
7. Degli-Esposti, M. A., Smyth, M. J. (2005) Close encounters of different kinds: dendritic cells and NK cells take center stage. Nat. Rev. Immunol. 5, 112-124.
8. Nishimura, T., Kitamura, H., Iwakabe, K., Yahata, T., Ohta, A., Sato, M., Takeda, K., Okumura, K., Van Kaer, L., Kawano, T., et al. (2000) The interface between innate and acquired immunity: glycolipid antigen presentation by CD1d-expressing dendritic cells to NKT cells induces the differentiation of antigen-specific cytotoxic T lymphocytes. Int. Immunol. 12, 987-994.
9. Nieda, M., Okai, M., Tazbirkova, A., Lin, H., Yamaura, A., Ide, K., Abraham, R., Juji, T., Macfarlane, D. J., Nicol, A. J. (2004) Therapeutic activation of Vα24+Vβ11+ NKT cells in human subjects results in highly coordinated secondary activation of acquired and innate immunity. Blood 103, 383-389.
10. Walzer, T., Dalod, M., Robbins, S. H., Zitvogel, L., Vivier, E. (2005) Natural-killer cells and dendritic cells: "l'union fait la force". Blood 106, 2252-2258.
11. Vitale, M., Della Chiesa, M., Carlomagno, S., Pende, D., Arico, M., Moretta, L., Moretta, A. (2005) NK-dependent DC maturation is mediated by TNFα and IFNγ released upon engagement of the NKp30 triggering receptor. Blood 106, 566-571.
12. Eberl, M., Jomaa, H., Hayday, A. C. (2004) Integrated immune responses to infection - cross-talk between human γδ T cells and dendritic cells. Immunology 112, 364-368.
13. Kunzmann, V., Kretzschmar, E., Herrmann, T., Wilhelm, M. (2004) Polyinosinic-polycytidylic acid-mediated stimulation of human γδT cells via CD11c dendritic cell-derived type I interferons. Immunology 112, 369-377.
14. Bonneville, M., Scotet, E. (2006) Human Vγ9Vδ2 T cells: promising new leads for immunotherapy of infections and tumors. Curr. Opin. Immunol. 18, 539-546.
15. Ferrarini, M., Ferrero, E., Dagna, L., Poggi, A., Zocchi, M. R. (2002) Human γδ T cells: a nonredundant system in the immune-surveillance against cancer. Trends Immunol. 23, 14-18.
16. Kabelitz, D., Wesch, D., Pitters, E., Zöller, M. (2004) Potential of human γδT lymphocytes for immunotherapy of cancer. Int. J. Cancer 112, 727-732.
17. Lopez, R. D. (2002) Human γδ-T cells in adoptive immunotherapy of malignant and infectious diseases. Immunol. Res. 26, 207-221.
18. Bauer, S., Groh, V., Wu, J., Steinle, A., Phillips, J. H., Lanier, L. L., Spies, T. (1999) Activation of NK cells and T cells by NKG2D, a receptor for stress-inducible MICA. Science 285, 727-729.
19. Das, H., Groh, V., Kuijl, C., Sugita, M., Morita, C. T., Spies, T., Bukowski, J. F. (2001) MICA engagement by human Vγ2Vδ2 T cells enhances their antigen-dependent effector function. Immunity 15, 83-93.
20. Groh, V., Rhinehart, R., Secrist, H., Bauer, S., Grabstein, K. H., Spies, T. (1999) Broad tumor-associated expression and recognition by tumor-derived γ δ T cells of MICA and MICB. Proc. Natl. Acad. Sci. USA 96, 6879-6884.
21. Liu, Z., Guo, B. L., Gehrs, B. C., Nan, L., Lopez, R. D. (2005) Ex vivo expanded human Vγ9Vδ2+ γδ-T cells mediate innate antitumor activity against human prostate cancer cells in vitro. J. Urol. 173, 1552-1556.
22. Viey, E., Fromont, G., Escudier, B., Morel, Y., Da Rocha, S., Chouaib, S., Caignard, A. (2005) Phosphostim-activated γ δ T cells kill autologous metastatic renal cell carcinoma. J. Immunol. 174, 1338-1347.
23. Tanaka, Y., Morita, C. T., Tanaka, Y., Nieves, E., Brenner, M. B., Bloom, B. R. (1995) Natural and synthetic non-peptide antigens recognized by human γ δ T cells. Nature 375, 155-158.
24. Bukowski, J. F., Morita, C. T., Brenner, M. B. (1999) Human γ δ T cells recognize alkylamines derived from microbes, edible plants, and tea: implications for innate immunity. Immunity 11, 57-65.
25. Kunzmann, V., Bauer, E., Wilhelm, M. (1999) γ/δ T-cell stimulation by pamidronate. N. Engl. J. Med. 340, 737-738.
26. Kunzmann, V., Bauer, E., Feurle, J., Weissinger, F., Tony, H. P., Wilhelm, M. (2000) Stimulation of γδ T cells by aminobisphosphonates and induction of antiplasma cell activity in multiple myeloma. Blood 96, 384-392.
27. Dieli, F., Vermijlen, D., Fulfaro, F., Caccamo, N., Meraviglia, S., Cicero, G., Roberts, A., Buccheri, S., D'Asaro, M., Gebbia, N., et al. (2007) Targeting human {γδ} T cells with zoledronate and interleukin-2 for immunotherapy of hormone-refractory prostate cancer. Cancer Res. 67, 7450-7457.
28. Marten, A., Lilienfeld-Toal, M., Buchler, M. W., Schmidt, J. (2007) Zoledronic acid has direct antiproliferative and antimetastatic effect on pancreatic carcinoma cells and acts as an antigen for δ2 γ/δ T cells. J. Immunother. 30, 370-377.
29. Mattarollo, S. R., Kenna, T., Nieda, M., Nicol, A. J. (2007) Chemotherapy and zoledronate sensitize solid tumor cells to Vγ9Vδ2 T cell cytotoxicity. Cancer Immunol. Immunother. 56, 1285-1297.
30. Carding, S. R., Egan, P. J. (2002) γδ T cells: functional plasticity and heterogeneity. Nat. Rev. Immunol. 2, 336-345.
31. García, V. E., Sieling, P. A., Gong, J., Barnes, P. F., Uyemura, K., Tanaka, Y., Bloom, B. R., Morita, C. T., Modlin, R. L. (1997) Single-cell cytokine analysis of γ δ T cell responses to nonpeptide mycobacterial antigens. J. Immunol. 159, 1328-1335.
32. Miyagawa, F., Tanaka, Y., Yamashita, S., Mikami, B., Danno, K., Uehara, M., Minato, N. (2001) Essential contribution of germline-encoded lysine residues in Jγ1.2 segment to the recognition of nonpeptide antigens by human γδ T cells. J. Immunol. 167, 6773-6779.
33. Kato, Y., Tanaka, Y., Tanaka, H., Yamashita, S., Minato, N. (2003) Requirement of species-specific interactions for the activation of human γ δ T cells by pamidronate. J. Immunol. 170, 3608-3613.
34. Conti, L., Casetti, R., Cardone, M., Varano, B., Martino, A., Belardelli, F., Poccia, F., Gessani, S. (2005) Reciprocal activating interaction between dendritic cells and pamidronate-stimulated γδ T cells: role of CD86 and inflammatory cytokines. J. Immunol. 174, 252-260.
35. Devilder, M. C., Maillet, S., Bouyge-Moreau, I., Donnadieu, E., Bonneville, M., Scotet, E. (2006) Potentiation of antigen-stimulated V γ 9V δ 2 T cell cytokine production by immature dendritic cells (DC) and reciprocal effect on DC maturation. J. Immunol. 176, 1386-1393.
36. Casorati, G., De Libero, G., Lanzavecchia, A., Migone, N. (1989) Molecular analysis of human γ/δ+ clones from thymus and peripheral blood. J. Exp. Med. 170, 1521-1535.
37. Muneta, Y., Nagaya, H., Minagawa, Y., Enomoto, C., Matsumoto, S., Mori, Y. (2004) Expression and one-step purification of bovine interleukin-21 (IL-21) in silkworms using a hybrid baculovirus expression system. Biotechnol. Lett. 26, 1453-1458.
38. Sasawatari, S., Tadaki, T., Isogai, M., Takahara, M., Nieda, M., Kakimi, K. (2006) Efficient priming and expansion of antigen-specific CD8+ T cells by a novel cell-based artificial APC. Immunol. Cell Biol. 84, 512-521.
39. Paczesny, S., Banchereau, J., Wittkowski, K. M., Saracino, G., Fay, J., Palucka, A. K. (2004) Expression of melanoma-specific cytotoxic CD8+ T cell precursors in patient with metastatic melanoma vaccinated with CD34+ progenitor-derived dendritic cells. J. Exp. Med. 199, 1503-1511.
40. Valmori, D., Pittet, M. J., Rimoldi, D., Lienard, D., Dunbar, R., Cerundolo, V., Lejeune, F., Cerottini, J. C., Romero, P. (1999) An antigen-targeted approach to adaptive transfer therapy of cancer. Cancer Res. 59, 2167-2173.
41. Schoenberger, S. P., Toes, R. E., van der Voort, E. I., Offringa, R., Melief, C. J. (1998) T-cell help for cytotoxic T lymphocytes is mediated by CD40-CD40L interactions. Nature 393, 480-483.
42. Ridge, J. P., Di Rosa, F., Matzinger, P. (1998) A conditioned dendritic cell can be a temporal bridge between a CD4+ T-helper and a T-killer cell. Nature 393, 474-478.
43. Guo, Z., Meng, L., Kim, O., Wang, J., Hart, J., He, G., Alegre, M. L., Thistlethwaite, J. R., Pearson, T. C., Larsen, C. P., Newell, K. A. (2001) CD8 T cell-mediated rejection of intestinal allografts is resistant to inhibition of the CD40/CD154 costimulatory pathway. Transplantation 71, 1351-1354.
44. Ford, M. L., Koehn, B. H., Wagener, M. E., Jiang, W., Gangappa, S., Pearson, T. C., Larsen, C. P. (2007) Antigen-specific precursor frequency impacts T cell proliferation, differentiation, and requirement for costimulation. J. Exp. Med. 204, 299-309.
45. Fujii, S., Shimizu, K., Hemmi, H., Fukui, M., Bonito, A. J., Chen, G., Franck, R. W., Tsuji, M., Steinman, R. M. (2006) Glycolipid α-C- galactosylceramide is a distinct inducer of dendritic cell function during innate and adaptive immune responses of mice. Proc. Natl. Acad. Sci. USA 103, 11252-11257.
46. Scott, M. J., Hoth, J. J., Stagner, M. K., Gardner, S. A., Peyton, J. C., Cheadle, W. G. (2004) CD40-CD154 interactions between macrophages and natural killer cells during sepsis are critical for macrophage activation and are not interferon γ dependent. Clin. Exp. Immunol. 137, 469-477.
47. Carbone, E., Ruggiero, G., Terrazzano, G., Palomba, C., Manzo, C., Fontana, S., Spits, H., Kärre, K., Zappacosta, S. (1997) A new mechanism of NK cell cytotoxicity activation: the CD40-CD40 ligand interaction. J. Exp. Med. 185, 2053-2060.
48. Adema, G. J., de Vries, I. J., Punt, C. J., Figdor, C. G. (2005) Migration of dendritic cell based cancer vaccines: in vivo veritas? Curr. Opin. Immunol. 17, 170-174.
49. Randolph, G. J., Angeli, V., Swartz, M. A. (2005) Dendritic-cell trafficking to lymph nodes through lymphatic vessels. Nat. Rev. Immunol. 5, 617-628.
50. Longman, R. S., Braun, D., Pellegrini, S., Rice, C. M., Darnell, R. B., Albert, M. L. (2007) Dendritic-cell maturation alters intracellular signaling networks, enabling differential effects of IFN-α/β on antigen cross-presentation. Blood 109, 1113-1122.
51. Brandes, M., Willimann, K., Moser, B. (2005) Professional antigen-presentation function by human γδ T cells. Science 309, 264-268.
52. Viey, E., Fromont, G., Escudier, B., Morel, Y., Da Rocha, S., Chouaib, S., Caignard, A. (2005) Phosphostim-activated γ δ T cells kill autologous metastatic renal cell carcinoma. J. Immunol. 174, 1338-1347.
53. Moser, B., Brandes, M. (2006) γδ T cells: an alternative type of professional APC. Trends Immunol. 27, 112-118.
54. Wilhelm, M., Kunzmann, V., Eckstein, S., Reimer, P., Weissinger, F., Ruediger, T., Tony, H. P. (2003) γδ T cells for immune therapy of patients with lymphoid malignancies. Blood 102, 200-206.